{
  "DOI": "10.1007/s10689-015-9788-x",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-015-9788-x",
  "alternative-id": [
    "9788"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Wevers",
      "given": "M. R.",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Schmidt",
      "given": "M. K.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Engelhardt",
      "given": "E. G.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Verhoef",
      "given": "S.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Hooning",
      "given": "M. J.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Kriege",
      "given": "M.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Seynaeve",
      "given": "C.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Collée",
      "given": "M.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "van Asperen",
      "given": "C. J.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Tollenaar",
      "given": "R. A. E. M.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Koppert",
      "given": "L. B.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Witkamp",
      "given": "A. J.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Rutgers",
      "given": "E. J. T.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Aaronson",
      "given": "N. K.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Rookus",
      "given": "M. A.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Ausems",
      "given": "M. G. E. M.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2015,
        2,
        20
      ]
    ],
    "date-time": "2015-02-20T09:14:34Z",
    "timestamp": 1424423674000
  },
  "deposited": {
    "date-parts": [
      [
        2019,
        3,
        26
      ]
    ],
    "date-time": "2019-03-26T22:53:21Z",
    "timestamp": 1553640801000
  },
  "indexed": {
    "date-parts": [
      [
        2023,
        9,
        15
      ]
    ],
    "date-time": "2023-09-15T20:28:13Z",
    "timestamp": 1694809693433
  },
  "is-referenced-by-count": 12,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "3",
  "issued": {
    "date-parts": [
      [
        2015,
        2,
        21
      ]
    ]
  },
  "journal-issue": {
    "issue": "3",
    "published-print": {
      "date-parts": [
        [
          2015,
          9
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://creativecommons.org/licenses/by/4.0",
      "content-version": "unspecified",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2015,
            2,
            21
          ]
        ],
        "date-time": "2015-02-21T00:00:00Z",
        "timestamp": 1424476800000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-015-9788-x.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-015-9788-x/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-015-9788-x",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "355-363",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2015,
        2,
        21
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2015,
        2,
        21
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2015,
        9
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1007/s10549-010-0805-3",
      "author": "DM Kolk van der",
      "doi-asserted-by": "crossref",
      "first-page": "643",
      "issue": "3",
      "journal-title": "Breast Cancer Res Treat",
      "key": "9788_CR1",
      "unstructured": "van der Kolk DM, de Bock GH, Leegte BK, Schaapveld M, Mourits MJ, de Vries J, van der Hout AH, Oosterwijk JC (2010) Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age. Breast Cancer Res Treat 124(3):643–651",
      "volume": "124",
      "year": "2010"
    },
    {
      "DOI": "10.1136/jmedgenet-2013-101974",
      "author": "RM Brohet",
      "doi-asserted-by": "crossref",
      "first-page": "98",
      "issue": "2",
      "journal-title": "J Med Genet",
      "key": "9788_CR2",
      "unstructured": "Brohet RM, Velthuizen ME, Hogervorst FB, Ej Meijers-Heijboer H, Seynaeve C, Collee MJ, Verhoef S, Ausems MG, Hoogerbrugge N, van Asperen CJ, Gomez GE, Menko F, Oosterwijk JC, Devilee P, Veer LJ, van Leeuwen FE, Easton DF, Rookus MA, Antoniou AC (2014) Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations. J Med Genet 51(2):98–107",
      "volume": "51",
      "year": "2014"
    },
    {
      "DOI": "10.1038/bjc.2011.120",
      "author": "K Metcalfe",
      "doi-asserted-by": "crossref",
      "first-page": "1384",
      "issue": "9",
      "journal-title": "Br J Cancer",
      "key": "9788_CR3",
      "unstructured": "Metcalfe K, Gershman S, Lynch HT, Ghadirian P, Tung N, Kim-Sing C, Olopade OI, Domchek S, McLennan J, Eisen A, Foulkes WD, Rosen B, Sun P, Narod SA (2011) Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. Br J Cancer 104(9):1384–1392",
      "volume": "104",
      "year": "2011"
    },
    {
      "DOI": "10.1186/bcr3369",
      "author": "K Rhiem",
      "doi-asserted-by": "crossref",
      "first-page": "R156",
      "issue": "6",
      "journal-title": "Breast Cancer Res",
      "key": "9788_CR4",
      "unstructured": "Rhiem K, Engel C, Graeser M, Zachariae S, Kast K, Kiechle M, Ditsch N, Janni W, Mundhenke C, Golatta M, Varga D, Preisler-Adams S, Heinrich T, Bick U, Gadzicki D, Briest S, Meindl A, Schmutzler RK (2012) The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort study. Breast Cancer Res 14(6):R156",
      "volume": "14",
      "year": "2012"
    },
    {
      "DOI": "10.1038/sj.bjc.6602703",
      "author": "TC Sprundel van",
      "doi-asserted-by": "crossref",
      "first-page": "287",
      "issue": "3",
      "journal-title": "Br J Cancer",
      "key": "9788_CR5",
      "unstructured": "van Sprundel TC, Schmidt MK, Rookus MA, Brohet R, van Asperen CJ, Rutgers EJ, Van’t Veer LJ, Tollenaar RA (2005) Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers. Br J Cancer 93(3):287–292",
      "volume": "93",
      "year": "2005"
    },
    {
      "DOI": "10.1002/14651858.CD002748.pub3",
      "doi-asserted-by": "crossref",
      "key": "9788_CR6",
      "unstructured": "Lostumbo L, Carbine NE, and Wallace J (2010) Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database Syst Rev 11:CD002748"
    },
    {
      "DOI": "10.1001/jama.2010.1237",
      "author": "SM Domchek",
      "doi-asserted-by": "crossref",
      "first-page": "967",
      "issue": "9",
      "journal-title": "JAMA",
      "key": "9788_CR7",
      "unstructured": "Domchek SM, Friebel TM, Singer CF, Evans DG, Lynch HT, Isaacs C, Garber JE, Neuhausen SL, Matloff E, Eeles R, Pichert G, Van t’veer L, Tung N, Weitzel JN, Couch FJ, Rubinstein WS, Ganz PA, Daly MB, Olopade OI, Tomlinson G, Schildkraut J, Blum JL, Rebbeck TR (2010) Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 304(9):967–975",
      "volume": "304",
      "year": "2010"
    },
    {
      "DOI": "10.1136/bmj.g226",
      "author": "K Metcalfe",
      "doi-asserted-by": "crossref",
      "first-page": "g226",
      "journal-title": "BMJ",
      "key": "9788_CR8",
      "unstructured": "Metcalfe K, Gershman S, Ghadirian P, Lynch HT, Snyder C, Tung N, Kim-Sing C, Eisen A, Foulkes WD, Rosen B, Sun P, Narod SA (2014) Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis. BMJ 348:g226",
      "volume": "348",
      "year": "2014"
    },
    {
      "DOI": "10.1007/s10549-013-2583-1",
      "author": "DG Evans",
      "doi-asserted-by": "crossref",
      "first-page": "135",
      "issue": "1",
      "journal-title": "Breast Cancer Res Treat",
      "key": "9788_CR9",
      "unstructured": "Evans DG, Ingham SL, Baildam A, Ross GL, Lalloo F, Buchan I, Howell A (2013) Contralateral mastectomy improves survival in women with BRCA1/2-associated breast cancer. Breast Cancer Res Treat 140(1):135–142",
      "volume": "140",
      "year": "2013"
    },
    {
      "DOI": "10.1200/JCO.2007.12.6078",
      "author": "KA Metcalfe",
      "doi-asserted-by": "crossref",
      "first-page": "1093",
      "issue": "7",
      "journal-title": "J Clin Oncol",
      "key": "9788_CR10",
      "unstructured": "Metcalfe KA, Lubinski J, Ghadirian P, Lynch H, Kim-Sing C, Friedman E, Foulkes WD, Domchek S, Ainsworth P, Isaacs C, Tung N, Gronwald J, Cummings S, Wagner T, Manoukian S, Moller P, Weitzel J, Sun P, Narod SA (2008) Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group. J Clin Oncol 26(7):1093–1097",
      "volume": "26",
      "year": "2008"
    },
    {
      "DOI": "10.1007/s10549-006-9423-5",
      "author": "KD Graves",
      "doi-asserted-by": "crossref",
      "first-page": "321",
      "issue": "3",
      "journal-title": "Breast Cancer Res Treat",
      "key": "9788_CR11",
      "unstructured": "Graves KD, Peshkin BN, Halbert CH, DeMarco TA, Isaacs C, Schwartz MD (2007) Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors. Breast Cancer Res Treat 104(3):321–329",
      "volume": "104",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.ejso.2005.05.007",
      "author": "DG Evans",
      "doi-asserted-by": "crossref",
      "first-page": "1112",
      "issue": "10",
      "journal-title": "Eur J Surg Oncol",
      "key": "9788_CR12",
      "unstructured": "Evans DG, Lalloo F, Hopwood P, Maurice A, Baildam A, Brain A, Barr L, Howell A (2005) Surgical decisions made by 158 women with hereditary breast cancer aged \u003c 50 years. Eur J Surg Oncol 31(10):1112–1118",
      "volume": "31",
      "year": "2005"
    },
    {
      "DOI": "10.1186/1472-6874-10-24",
      "author": "AF Howard",
      "doi-asserted-by": "crossref",
      "first-page": "24",
      "journal-title": "BMC Womens Health",
      "key": "9788_CR13",
      "unstructured": "Howard AF, Bottorff JL, Balneaves LG, Kim-Sing C (2010) Women’s constructions of the ‘right time’ to consider decisions about risk-reducing mastectomy and risk-reducing oophorectomy. BMC Womens Health 10:24",
      "volume": "10",
      "year": "2010"
    },
    {
      "key": "9788_CR14",
      "unstructured": "The National Breast cancer Organisation the Netherlands (NABON) and Comprehensive Cancer Center the Netherlands (VIKC). The National Breast cancer Organisation the Netherlands (NABON)—Breast Cancer Guideline 2.0. http://www.oncoline.nl/index.php?pagina=/richtlijn/item/pagina.php\u0026richtlijn_id=608 . 2008"
    },
    {
      "key": "9788_CR15",
      "unstructured": "The Netherlands Foundation for the Detection of Hereditary Tumours (STOET) and the Dutch Society of Clinical Genetics (VKGN) (2010) Erfelijke tumoren: richtijnen voor diagnostiek en preventie, 4 edn"
    },
    {
      "key": "9788_CR16",
      "unstructured": "Comprehensive Cancer Center the Netherlands (IKNL). Breast cancer guideline 2.0. www.oncoline.nl/mammacarcinoom . 2013"
    },
    {
      "DOI": "10.1111/j.1365-2354.2008.01065.x",
      "author": "E Riel van",
      "doi-asserted-by": "crossref",
      "first-page": "369",
      "issue": "3",
      "journal-title": "Eur J Cancer Care (Engl)",
      "key": "9788_CR17",
      "unstructured": "van Riel E, Warlam-Rodenhuis CC, Verhoef S, Rutgers EJ, Ausems MG (2010) BRCA testing of breast cancer patients: medical specialists’ referral patterns, knowledge and attitudes to genetic testing. Eur J Cancer Care (Engl) 19(3):369–376",
      "volume": "19",
      "year": "2010"
    },
    {
      "DOI": "10.1186/1471-2407-12-320",
      "author": "KJ Watts",
      "doi-asserted-by": "crossref",
      "first-page": "320",
      "journal-title": "BMC Cancer",
      "key": "9788_CR18",
      "unstructured": "Watts KJ, Meiser B, Mitchell G, Kirk J, Saunders C, Peate M, Duffy J, Kelly PJ, Gleeson M, Barlow-Stewart K, Rahman B, Friedlander M, Tucker K (2012) How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancer. BMC Cancer 12:320",
      "volume": "12",
      "year": "2012"
    },
    {
      "DOI": "10.1093/annonc/mdt422",
      "author": "L Cortesi",
      "doi-asserted-by": "crossref",
      "first-page": "57",
      "issue": "1",
      "journal-title": "Ann Oncol",
      "key": "9788_CR19",
      "unstructured": "Cortesi L, Razzaboni E, Toss A, De ME, Marchi I, Medici V, Tazzioli G, Andreotti A, De SG, Pignatti M, Federico M (2014) A rapid genetic counselling and testing in newly diagnosed breast cancer is associated with high rate of risk-reducing mastectomy in BRCA1/2-positive Italian women. Ann Oncol 25(1):57–63",
      "volume": "25",
      "year": "2014"
    },
    {
      "DOI": "10.1186/bcr2194",
      "author": "B Meiser",
      "doi-asserted-by": "crossref",
      "first-page": "216",
      "issue": "6",
      "journal-title": "Breast Cancer Res",
      "key": "9788_CR20",
      "unstructured": "Meiser B, Tucker K, Friedlander M, Barlow-Stewart K, Lobb E, Saunders C, Mitchell G (2008) Genetic counselling and testing for inherited gene mutations in newly diagnosed patients with breast cancer: a review of the existing literature and a proposed research agenda. Breast Cancer Res 10(6):216",
      "volume": "10",
      "year": "2008"
    },
    {
      "DOI": "10.1186/1471-2407-11-6",
      "author": "MR Wevers",
      "doi-asserted-by": "crossref",
      "first-page": "6",
      "journal-title": "BMC Cancer",
      "key": "9788_CR21",
      "unstructured": "Wevers MR, Ausems MG, Verhoef S, Bleiker EM, Hahn DE, Hogervorst FB, van der Luijt RB, Valdimarsdottir HB, van Hillegersberg R, Rutgers EJ, Aaronson NK (2011) Behavioral and psychosocial effects of rapid genetic counseling and testing in newly diagnosed breast cancer patients: design of a multicenter randomized clinical trial. BMC Cancer 11:6",
      "volume": "11",
      "year": "2011"
    },
    {
      "DOI": "10.1245/s10434-008-0160-3",
      "author": "PL Mai",
      "doi-asserted-by": "crossref",
      "first-page": "3415",
      "issue": "12",
      "journal-title": "Ann Surg Oncol",
      "key": "9788_CR22",
      "unstructured": "Mai PL, Lagos VI, Palomares MR, Weitzel JN (2008) Contralateral risk-reducing mastectomy in young breast cancer patients with and without genetic cancer risk assessment. Ann Surg Oncol 15(12):3415–3421",
      "volume": "15",
      "year": "2008"
    },
    {
      "DOI": "10.1200/JCO.2012.43.2013",
      "author": "AS Reiner",
      "doi-asserted-by": "crossref",
      "first-page": "433",
      "issue": "4",
      "journal-title": "J Clin Oncol",
      "key": "9788_CR23",
      "unstructured": "Reiner AS, John EM, Brooks JD, Lynch CF, Bernstein L, Mellemkjaer L, Malone KE, Knight JA, Capanu M, Teraoka SN, Concannon P, Liang X, Figueiredo JC, Smith SA, Stovall M, Pike MC, Haile RW, Thomas DC, Begg CB, Bernstein JL (2013) Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women’s Environmental Cancer and Radiation Epidemiology Study. J Clin Oncol 31(4):433–439",
      "volume": "31",
      "year": "2013"
    },
    {
      "DOI": "10.1089/gtmb.2008.0067",
      "author": "MS Beattie",
      "doi-asserted-by": "crossref",
      "first-page": "51",
      "issue": "1",
      "journal-title": "Genet Test Mol Biomarkers",
      "key": "9788_CR24",
      "unstructured": "Beattie MS, Crawford B, Lin F, Vittinghoff E, Ziegler J (2009) Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers. Genet Test Mol Biomarkers 13(1):51–56",
      "volume": "13",
      "year": "2009"
    },
    {
      "DOI": "10.1007/s10549-009-0476-0",
      "author": "A Pijpe",
      "doi-asserted-by": "crossref",
      "first-page": "235",
      "issue": "1",
      "journal-title": "Breast Cancer Res Treat",
      "key": "9788_CR25",
      "unstructured": "Pijpe A, Manders P, Brohet RM, Collee JM, Verhoef S, Vasen HF, Hoogerbrugge N, van Asperen CJ, Dommering C, Ausems MG, Aalfs CM, Gomez-Garcia EB, Van’t Veer LJ, van Leeuwen FE, Rookus MA (2010) Physical activity and the risk of breast cancer in BRCA1/2 mutation carriers. Breast Cancer Res Treat 120(1):235–244",
      "volume": "120",
      "year": "2010"
    },
    {
      "DOI": "10.1200/JCO.2010.29.4041",
      "author": "TA King",
      "doi-asserted-by": "crossref",
      "first-page": "2158",
      "issue": "16",
      "journal-title": "J Clin Oncol",
      "key": "9788_CR26",
      "unstructured": "King TA, Sakr R, Patil S, Gurevich I, Stempel M, Sampson M, Morrow M (2011) Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. J Clin Oncol 29(16):2158–2164",
      "volume": "29",
      "year": "2011"
    },
    {
      "DOI": "10.1245/s10434-012-2299-1",
      "author": "A Chung",
      "doi-asserted-by": "crossref",
      "first-page": "2600",
      "issue": "8",
      "journal-title": "Ann Surg Oncol",
      "key": "9788_CR27",
      "unstructured": "Chung A, Huynh K, Lawrence C, Sim MS, Giuliano A (2012) Comparison of patient characteristics and outcomes of contralateral prophylactic mastectomy and unilateral total mastectomy in breast cancer patients. Ann Surg Oncol 19(8):2600–2606",
      "volume": "19",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.amjsurg.2011.04.001",
      "author": "M Howard-McNatt",
      "doi-asserted-by": "crossref",
      "first-page": "298",
      "issue": "3",
      "journal-title": "Am J Surg",
      "key": "9788_CR28",
      "unstructured": "Howard-McNatt M, Schroll RW, Hurt GJ, Levine EA (2011) Contralateral prophylactic mastectomy in breast cancer patients who test negative for BRCA mutations. Am J Surg 202(3):298–302",
      "volume": "202",
      "year": "2011"
    },
    {
      "DOI": "10.1245/s10434-010-1259-x",
      "author": "CC Stucky",
      "doi-asserted-by": "crossref",
      "first-page": "330",
      "issue": "Suppl 3",
      "journal-title": "Ann Surg Oncol",
      "key": "9788_CR29",
      "unstructured": "Stucky CC, Gray RJ, Wasif N, Dueck AC, Pockaj BA (2010) Increase in contralateral prophylactic mastectomy: echoes of a bygone era? Surgical trends for unilateral breast cancer. Ann Surg Oncol 17(Suppl 3):330–337",
      "volume": "17",
      "year": "2010"
    },
    {
      "DOI": "10.1016/S1470-2045(13)70047-0",
      "author": "JA Murphy",
      "doi-asserted-by": "crossref",
      "first-page": "e262",
      "issue": "7",
      "journal-title": "Lancet Oncol",
      "key": "9788_CR30",
      "unstructured": "Murphy JA, Milner TD, O’Donoghue JM (2013) Contralateral risk-reducing mastectomy in sporadic breast cancer. Lancet Oncol 14(7):e262–e269",
      "volume": "14",
      "year": "2013"
    },
    {
      "DOI": "10.1007/s10549-009-0497-8",
      "author": "BE Kiely",
      "doi-asserted-by": "crossref",
      "first-page": "715",
      "issue": "3",
      "journal-title": "Breast Cancer Res Treat",
      "key": "9788_CR31",
      "unstructured": "Kiely BE, Jenkins MA, McKinley JM, Friedlander ML, Weideman P, Milne RL, McLachlan SA, Hopper JL, Phillips KA (2010) Contralateral risk-reducing mastectomy in BRCA1 and BRCA2 mutation carriers and other high-risk women in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab). Breast Cancer Res Treat 120(3):715–723",
      "volume": "120",
      "year": "2010"
    }
  ],
  "reference-count": 31,
  "references-count": 31,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-015-9788-x"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Timing of risk reducing mastectomy in breast cancer patients carrying a BRCA1/2 mutation: retrospective data from the Dutch HEBON study"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "14"
}